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Abstract
Real-time in vivo imaging of the microvasculature may help both earlier clinical detection of disease and the un-
derstanding of tumor–host interaction at various stages of progression. In vivo confocal and multiphoton micros-
copy is often hampered by bulky optics setup and has limited access to internal organs. A fiber-optic setup avoids
these limitations and offers great user maneuverability. We report here the in vivo validation of a fiber-optic con-
focal fluorescence microprobe imaging system. In addition, we developed an automated fractal-based image
analysis to characterize microvascular morphology based on vessel diameter distribution, density, volume fraction,
and fractal dimension from real-time data. The system is optimized for use in the far-red and near-infrared region.
The flexible 1.5-mm-diameter fiber-optic bundle and microprobe enable great user maneuverability, with a field of
view of 423 × 423 μm and a tissue penetration of up to 15 μm. Lateral and axial resolutions are 3.5 and 15 μm. We
show that it is possible to obtain high temporal and spatial resolution images of virtually any abdominal viscera
in situ using a far-red blood pool imaging probe. Using an orthotopic model of pancreatic ductal adenocarcinoma,
we characterized the tumor surface capillary and demonstrated that the imaging system and analysis can quanti-
tatively differentiate between the normal and tumor surface capillary. This clinically approved fiber-optic system,
together with the fractal-based image analysis, can potentially be applied to characterize other tumors in vivo and
may be a valuable tool to facilitate their clinical evaluation.
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Introduction
Tumor capillary is known be more tortuous, leaky, dense, and dis-
organized in appearance compared to normal capillaries [1,2]. In vivo
quantification of changes in vascular morphology both overtime and
in comparison to normal capillaries remains challenging, especially
for deep tissues. Current approaches to characterize tumor capillary,
such as staining for endothelial markers, are mostly qualitative and
lack many of the objective measures that define the vasculature [3–
5]. Moreover, histologic diagnosis is often a terminal procedure for
animal models of tumors, and this limits its use for tracking temporal
changes. Several reports have documented quantification of tumor
capillary using a dorsal skin-fold window chamber [3,6]. Despite
these advances, the window chamber model relies on subcutaneous
tumor xenografts and thus limits examination of the pivotal role that
the tumor’s native microenvironment plays on microvascular changes
[7]. This limitation can become pronounced when studying tumors
such as pancreatic ductal adenocarcinoma (PDAC), which triggers an
intense fibrotic response from the pancreas [8]. Subcutaneous models
do not fully recapitulate the increasingly recognized impact of extra-
cellular matrix on both the tumor and its vasculature.
Given these limitations, in the present study, we sought to evalu-
ate the potential for in situ quantitative imaging of tumor surface
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capillary temporally using a minimally invasive approach. The sys-
tem, which includes optics, hardware, developed software, and im-
aging agents, may be used in genetically engineered mice and has
the potential for human clinical application. The imaging micro-
probe is connected to 30,000 fiber-optic threads that enable point-
to-point real-time detection at 12 frames/sec. The microprobe’s
flexibility and size (1.5 mm in diameter; Figure 1) allow for great user
maneuverability to scan tissues in situ at angles that would not be
possible with any available confocal microscope objective. To make
the imaging and vessel morphometric analysis more quantitative and
reproducible, we developed an algorithm that automated the delinea-
tion of vessels from raw images and computed their mean diameter
and density. We also applied fractal geometry to physically describe
the complexity of tumor vessels. Specifically, we used an orthotopic
mouse model of PDAC to study changes in microvasculature pheno-
types. Of note, our vessel segmentation algorithm enabled us to com-
pute the diameter along the entire length of any detected vessel at an
interval of 1 pixel. As such, we could construct histograms of vessel
diameter distribution and investigate whether PDAC diameter histo-
gram is distinct from that of the normal pancreas.
Figure 1. Vessel segmentation algorithm was applied to raw images to outline the border and midline of detected vasculature networks.
On the basis of this process, quantitative morphology and fractal analyses could be applied. (a) The tip of the microprobe is 1.5 mm in
diameter, enabling it to explore internal organs with only a small incision. (b) Microvasculature of pancreatic ductal adenocarcinoma. (c)
After segmentation algorithm was applied, information on vessel density, diameter, volume fraction, and diameter distribution were
obtained. (d) Image from (c) was RGB-filtered to select the blue channel that contained the vessel midline. Thresholding and binarization
were applied to the resultant image to give a skeletonized image with only the vasculature outline. Fractal analysis was applied to this
outline. Grid counting method was applied to obtain the fractal parameter fractal dimension. Grids of varying sizes were overlaid on the
image. The number of grids containing a vessel segment (shown by the light green–filled boxes) at each grid size was plotted against
the grid size at logarithmic scales (e). A best-fit regression line was drawn to fit the resultant points (shown here with open circles), and
the negative slope of this line denotes fractal dimension, which serves as a measure of the vasculature’s complexity. For each image,
four such lines would be drawn, each of which represented a different starting point to overlie the grids. The four lines (shown here with
different colors) were averaged to give the final fractal dimension for the image.
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Materials and Methods
Fiber-Optic Laser Microprobe
The imaging system, Cellvizio (Mauna Kea Technologies, Paris,
France), has three components: a fiber-optic microprobe, a laser scan-
ning unit, and a computer. A custom-made 660-nm laser source is
scanned by two mirrors on the proximal surface of a fiber bundle
made of 30,000 optical fibers, resulting in a 12-Hz frame rate.
The laser was sequentially directed into each fiber to reach the tissue.
The fluorescent emitted light is collected back into the same fiber
that was used for illumination. The small core diameter of each fiber
acts as the pinhole both for excitation and for collection, giving the
probe its optical sectioning capability. The imaging microprobe has a
tissue penetration depth of 15 μm, and this limits our measurement
of vascular phenotype to the surface of the orthotopic tumor and
normal organs.
A raw image is reconstructed from the signals collected from each
fiber and a real-time processing algorithm reconstructs the image to
compensate for irregularities in the fiber bundle packing pattern and
for fiber–fiber transmission variability. The signal-to-noise ratio
(SNR) was measured at different levels of signal, which the system
registers as arbitrary digital unit (ADU). The SNR was taken as
the ratio of mean gray level against the SD on a known uniform sig-
nal, ranging from 1000 to 7000 ADU. This range covers the signal
level encountered in our application. The 1.5-mm-diameter micro-
probe’s field of view is 423 × 423 μm. Lateral and axial resolutions
are 3.5 and 15 μm, respectively (Figure 1). This method had been
previously compared to intravital fluorescent microscopy, and vessel
diameter measurement from both methodologies correlated statisti-
cally [2]. To validate this method, immunohistochemical (IHC)
staining with antimouse CD31 antibody (Santa Cruz Biotechnolo-
gies, Santa Cruz, CA) was used to independently measure vessel di-
ameters in both normal organs and PDAC. Specifically, normal organs
and PDAC were harvested (n = 7 from each). These were the same
organs that were previously imaged with fiber-optic confocal micro-
probe. Three surface slices were made at different angles on all nor-
mal organs and PDAC. This was to simulate the areas of vasculature
that were imaged. Within each slice, two different views at original
magnifications of ×200 were randomly selected, and the stained ves-
sel’s diameter was manually selected and length measured with the
software OsiriX (Geneva, Switzerland). In all cases, the shortest dis-
tance between two points from an enclosed stained vessel was chosen
to avoid overestimation of vessel diameter by obtaining the diameter
from vessels that were cut along its longitudinal axis.
Imaging Probe
A fluorescent blood pool agent was used to image the micro-
vasculature of different organs and murine orthotopic pancreatic duc-
tal tumor (Angiosense 680 IVM; VisEn Medical, Woburn, MA).
This probe circulated inside normal blood vessels for up to 2 hours
and has a molecular weight of 250 kg/mol. The probe has an exci-
tation at 680 ± 10 nm and an emission at 700 ± 10 nm. Excitation
was provided by a 660-nm laser.
Vessel Segmentation
The segmentation algorithm defines the border and midline of
blood vessels in the image plane, and it follows the principles pub-
lished by Krissian et al. [9]. Briefly described, vessels were modeled
as tubular structures with Gaussian profiles. In this model, vessel
centerlines can be detected as ridges that act as maxima of intensity
in the direction of surface main curvature. To account for different
vessel radii, ridges are detected at different scales; for each scale, a
medial response is computed, and only the maxima of this response
through the scales are kept. The scale at which a ridge is detected
leads to an estimate of vessel radius, which is refined in a later stage
through local motion of estimated edges toward image gradient
maxima. The result of the segmentation algorithm is several sets of
connected points, each set representing a vessel centerline, with a
local radius estimation associated with each point of the centerline.
Starting from this result, one can easily compute statistics on vessel
diameters and vessel density. In the final image, the vessel centerline
was noted in blue, and the border in green (Figure 1). Vessel diame-
ter was recorded in micrometers.
Vessel diameter distribution histogram was constructed by taking
the diameter along the length of the detected vessel and plotting the
proportion of a particular-sized vessel at an interval of 1 μm.
Vessel density was expressed as the percentage of the total length of
vessels in an image over the area of the image plane. In other words,
vessel density was measured irrespective of changes in vascular di-
ameter. To quantify the combined effect of both vessel density and
vessel diameter, we used the parameter vascular volume fraction.
Vascular volume fraction indicated the percentage of tissue space
occupied by the vasculature, and it was here computed as the fraction
of space occupied by the vessels within the optical section. Vessels
were assumed to have a cylindrical shape, and the vessel volume
could be obtained using the cylinder volume equation: volume =
πr2L, where r is the radius and L is the total length of the vessel,
which could be obtained from the vessel density.
To minimize background, we consistently subtracted signal with
signal intensity lower than 0.01% of the maximum and vessel length
shorter than 10 μm. Vessel diameter, density, and complexity were
also plotted into a three-dimensional (3D) scatterplot using the
Grapher, a freeware available through Mac OS X and above.
Fractal Analysis
Each segmented image was split into RGB channels, and the blue
channel, which contains the vessel centerline, was selected. The re-
sultant image was binarized and skeletonized using ImageJ (NIH,
Bethesda, MD). The microvasculature was now denoted by black
lines with a pixel diameter against a white background, and this bi-
nary image was processed using FracLac, an ImageJ plug-in, for frac-
tal analysis.
Fractal dimension (D) was calculated using the grid-counting
method [10]. Briefly, grids of various size length (ɛ), from 1 pixel
to 45% of the image area, were used to cover the entire image,
and the number of grid that contains a vessel segment, N (ɛ), was
registered for each grid size. D can be obtained by taking the negative
of the slope of a double-logarithmic plot between N (ɛ) and ɛ. Stated
mathematically, D is estimated using the following equation:
D ¼ lim
ε→0
lnN ðεÞ
lnð1=εÞ ð1Þ
Stated formally, fractal dimension is the derivative of structural detail
with respect to magnification [5]. For images that consist of lines,
D always varies between 1 and 2, with the higher value representing
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greater complexity. In our study, D for each image was obtained as
the average of four global scans initiated at randomly selected initial
point. Because nonlinearity of the double-logarithmic plot occurs
as ɛ approaches to its minimum and maximum, we used a slope-
corrected D and included only the linear portion of the plot in
our calculation of complexity (Figure 1). This measuring procedure
was calibrated with shapes of known fractal dimension with an in-
accuracy of less than 3%.
Shape heterogeneity was reflected by the lacunarity (Λ) using the
covariance method [11]. Lacunarity is a parameter that measures
nonuniformity in an image. If every part of an image resembles every
other part, Λ would be low. Λ takes on a value between 0 and 1 and
can be calculated from the mean (μ) and variance (σ2) of the number
of pixels in a grid of a given size (ɛ) using the following equation:
Λ ¼P
ε
Λε
N
¼P
ε
σε=μεð Þ2
N
ð2Þ
σ 2 is normalized against μ2 at each ɛ to give Λɛ. Λ is then derived by
taking the average of all Λɛ with a total number of scales N. Image
analysis was streamlined and automated using Java script.
Cell Culture
Primary murine cell lines (NB587 and NB743) were isolated from
mice harboring pancreas specific activating mutation of K-ras and
deletion of Ink4a and Arf genes. Mice with these mutations de-
velop spontaneous PDAC in 8 to 11 weeks and recapitulated the
clinical and histologic features of human PDAC [12]. Cells were
plated and maintained in growth medium (Dulbecco’s modified
Eagle’s medium plus 10% FBS) in a humidified incubator at 37°
C, 5% CO2, and 95% humidity. At near confluence, cells were tryp-
sinized and resuspended in HPSS and stored in ice for subsequent
orthotopic implantation.
Animal Model and Surgery
The study was approved by the institutional animal care commit-
tee. All the mice were operated under gas anesthesia (2% isoflurane
in oxygen at 2 L/min) delivered by facemask. Age-matched female
nude mice were used for our orthotopic pancreatic cancer model
and for the imaging of normal organs. A 1-cm incision was per-
formed in the left upper quadrant of the mouse abdomen. Skin
and muscular wall were opened to allow exposure of the pancreas.
The spleen was gently exteriorized using a forceps, completely expos-
ing the pancreatic body and tail. A 1-ml syringe attached to a 31G
needle was used to inject primary PDAC cell lines into the tail of the
pancreas. Muscular wall and skin were then closed separately using
nylon monofilament 6-0. We then waited up to 2 weeks to allow for
tumor growth and reopened the mouse on days 7 and 14 using the
same incision for pancreatic imaging with the flexible laser micro-
probe. Angiosense 680 IVM (VisEn Medical) was diluted with saline
1:3, and 100 μl was injected intravenously to the tail immediately
before the procedure for visualization of the pancreatic microvascu-
lature. The microprobe at the end of the fiber-optic threads was then
gently placed on the surface of the liver, kidney, colon, pancreas, and
psoas muscle. For mice bearing orthotopic PDAC (n = 7 for each of
the two tumor lines), real-time videos of the microvasculature were
acquired near the pancreatic tumor surface. Tumor area was mea-
sured bidirectionally using a digital caliper. Five nonoverlapping
views of each organ were obtained from each of the mice (n = 7).
In addition, intravital multichannel confocal microscopy (Model
IV-100; Olympus Corporation, Tokyo, Japan) was used to explore
the spatial relation between the microvasculature at tumor surface
and the actual tumor. Both NB743 and NB587 primary cell lines
were infected with retrovirus encoding the GFP gene.
Statistical Analysis
All values in the study are expressed as mean ± SEM. Analysis
on normal organs and tumor surface capillary was each performed
on seven mice. No statistical comparison was made among the nor-
mal organs examined. For validation of our method with CD-31
IHC staining, data were compared within each organ group. For
tumor area measurement, statistical comparison was made between
NB587 and NB743 cell lines at weeks 1 and 2 (n = 7 for each pri-
mary cell line). For vessel morphometric analyses, comparison be-
tween NB587 and control, as well as between NB743 and control,
was made at weeks 1 and 2 (n = 7 for each group). The control group
consisted of mice receiving saline injection to the pancreas. A two-
tailed t-test was used to determine significance, whereby P < .05 in-
dicates significance.
Result
Organ-Specific Microvascular Profile
The SNR varied from 10 to 29 at the typically found input signal
range of 1000 to 7000 ADU. There was no procedure related to
mortality or bleeding. Motion artifact due to respiration occurred ap-
proximately once every 4 seconds and was minimized by slightly lift-
ing the pancreas toward the spleen. The five abdominal organs
imaged all had distinct morphologic features that could be appreci-
ated qualitatively (Figure 2). In addition, each organ had a unique
profile of vessel diameter, density, fractal dimension, and lacunarity.
The kidney had the largest vessel diameter (15.31 ± 0.21 μm, with
pancreas 10.52 ± 0.17 μm, liver 10.71 ± 0.33 μm, colon 9.04 ±
0.24 μm, and psoas muscles 13.50 ± 0.14 μm; Figure 3a). The liver
had the highest density, expressed in % of length/area (5.55 ± 0.11,
with pancreas 2.88 ± 0.17, kidney 3.22 ± 0.11, colon 3.19 ± 0.14,
and psoas muscles 3.10 ± 0.34; Figure 3b). The kidney had the larg-
est volume fraction, consistent with the notion that the organ re-
ceives up to 20% of the cardiac output (9.68 ± 0.23%, with
pancreas 4.14 ± 0.22%, liver 8.24 ± 0.27%, colon 3.41 ± 0.23%,
and psoas muscles 7.41 ± 0.13%; Figure 3c).
Our vessel diameter data were validated with IHC staining with
anti-CD31 antibody. No statistically significant difference was ob-
served between these two techniques (P < .05, n = 4). Specifically,
IHC staining showed the pancreatic vessel diameter to be 10.07 ±
0.78 μm, with colon 8.57 ± 0.76 μm, kidneys 16.42 ± 2.54 μm,
psoas muscles 12.95 ± 0.87 μm, NB587 PDAC 10.92 ± 1.33,
and NB743 PDAC 13.29 ± 1.97 (both PDAC lines were mea-
sured 2 weeks after tumor implantation). In addition, our vessel di-
ameter data fell within the range of previously published values on
mouse cremaster muscle microvasculature by Laemmel et al. [2].
In that particular study, the authors compared the fiber-optic con-
focal laser microprobe imaging system with intravital fluorescence
microcopy and found that the two methods shared high correlation
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(r2 = 0.98), with a mean difference between the two methods made
on the same vessel equal to 1.2 μm over the entire range of diame-
ter measured.
With regard to the fractal parameters, the liver vasculature also had
the highest fractal dimension (1.54 ± 0.01, with pancreas 1.36 ±
0.01, kidney 1.40 ± 0.01, colon 1.27 ± 0.01, and psoas muscles
1.31 ± 0.03; Figure 3d ). The vessel lacunarity was similar in pan-
creas, kidneys, colon, and psoas muscles (0.30 ± 0.02, 0.29 ± 0.01,
0.32 ± 0.01, and 0.29 ± 0.02), whereas the liver sinusoids had the
lowest lacunarity (0.24 ± 0.01; see Figure 3e). The unique phenotypic
profile of each organ’s microvasculature could be graphically repre-
sented by using vessel diameter, density, and fractal dimension as the
three axes (Figure 3f ). The graph shows that points representing each
organ cluster and occupy a unique space in this vector field.
Phenotypic Confirmation of PDAC
All mice injected with primary PDAC cell lines developed tumors.
By day 14, all tumors showed extensive infiltration throughout the
pancreas. Histologic finding revealed cellular atypia, extensive desmo-
plasia, and areas of invasion by malignant ductal cells beyond the
basement membrane (Figure 4). Both NB587 and NB743 primary
cell lines gave rise to these findings, and these features were also con-
sistent with those previously reported by investigators using the same
primary cell lines [12]. The tumors were firm to palpation because of
the collagen content.
Intravital multichannel confocal microscopy revealed extensive
network of microvasculature near the surface of the tumor (Fig-
ure 4d ). These surface vessels appear terminally branched and they
traverse through the tumors directly. Their diameter also falls into the
range obtained by the fiber-optic microprobe.
Temporal Changes in PDAC Microvasculature
Both NB587 and NB743 primary cell lines expanded to macroscopi-
cally visible tumors by week 1 (8.73 ± 3.70 and 9.00 ± 2.00 mm2,
respectively). By week 2, all tumors had quadrupled in size (46.94 ±
18.77 and 52.00 ± 15.29 mm2, respectively; Figure 5a).
By week 1, only vessel density and vascular volume fraction
showed significant change compared to the controls receiving saline
injection. For NB587 and NB743 tumors, vessel densities were
3.64 ± 0.21% and 3.49 ± 0.22%, respectively, compared to the con-
trol group at 2.83 ± 0.11% (Figure 5c). Vascular volume fractions
were 5.56 ± 0.42% and 5.60 ± 0.49%, respectively, compared to
the control group at 4.19 ± 0.26% (Figure 5d ).
Vessel diameter and fractal dimension did not differ significantly
from the control group by week 1. Mean vessel diameters were
10.83 ± 0.40 μm for NB587 and 10.98 ± 0.22 μm for NB743, com-
pared to the control group at 10.56 ± 0.20 μm (Figure 5b). Com-
plexities were 1.39 ± 0.02 for NB587 and 1.37 ± 0.02 for NB743
compared to the control at 1.36 ± 0.01 (Figure 5e).
By week 2, all the vascular phenotypes except for lacunarity be-
came significantly different between the control group and the two
PDAC tumor lines. Vessel diameters were 11.7 ± 0.29 μm for
NB587 and 12.32 ± 0.22 μm for NB743 compared to the con-
trol at 10.8 ± 0.28 μm (Figure 5b). Vessel densities were 3.94 ±
Figure 2.Microvasculature of abdominal organs in situ: pancreas (a), kidney capsule (b), psoas muscles (c), liver sinusoids (d), and colon
(e). Yellow scale bar, 100 μm.
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0.33% for NB587 and 3.84 ± 0.17% for NB743 compared to the
control at 3.11 ± 0.16% (Figure 5c). Vascular volume fractions
were higher for NB587 and NB743 compared to the control (7.14 ±
0.72% and 7.73 ± 0.48% vs 4.73 ± 0.27%; Figure 5d ). Vascular fractal
dimension was 1.42 ± 0.03 for NB587 and 1.43 ± 0.01 for NB743
compared to the control at 1.36 ± 0.01 (Figure 5e). No significant
change was found for vascular lacunarity when measured at weeks 1
and 2 (NB587 0.30 ± 0.01 and NB743 0.29 ± 0.01 vs control
0.30 ± 0.01 at week 1, and NB587 0.29 ± 0.01 and NB743 0.28 ±
0.01 vs control 0.30 ± 0.01 at week 2; Figure 5f ).
When plotted on the 3D scatterplot according to the vessel diame-
ter, density, and fractal dimension, both tumor lines mixed into one
cluster distinct from that of the control group (Figure 5g). The tumor
cluster showed an upward shift along the diameter, density, and frac-
tal dimension axes.
Vessel Diameter Histogram
Normal pancreatic surface capillary’s diameter histogram formed
three peaks (Figure 6). First peak (group 1) consisted of capillaries
with diameter from 0 to 10 μm. This group had the highest propor-
tion of the total capillaries (52.33 ± 12.42%). The next peak (group 2)
consisted of capillaries with diameter from 10 to 16 μm, and it rep-
resented 31.21 ± 2.25% of the total capillaries. The last major peak
(group 3) of capillaries consisted of those with diameter from 16 to
26 μm, and it represented 4.13 ± 0.98% of the total capillaries.
Figure 3. Quantification of microvasculature morphology of abdominal organs. (a) Vessel diameter. (b) Vessel density was computed as
a percentage of vessel length over the image area. (c) Vascular volume fraction was computed from vessel density and diameter. Fractal
analysis of fractal dimension (d) and lacunarity (e). (f) Organ-specific clustering in this 3D scatterplot suggested that these different
organs’ microvasculature has a unique set of diameter, density, and fractal dimension. Each point represented one measurement. Re-
sults were obtained from four different animals.
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Tumor capillary diameter histogram also formed three peaks, but
their proportion differed significantly from that of the normal pancre-
atic capillaries. Group 1 capillaries comprised 35.55 ± 6.11% of the
total capillaries, whereas groups 2 and 3 comprised 45.15 ± 4.88%
and 13.76 ± 0.85% of the total capillaries. Compared to the normal
pancreatic capillaries, PDAC surface capillaries represented a statisti-
cally significant shift from group 1 to the groups 2 and 3 capillaries.
In other words, PDAC surface capillaries were larger and might con-
tribute to the increased volume fraction observed in tumors.
Discussion
The salient findings of the present investigation are as follows: 1)
the flexible fiber-optic microprobe can obtain high-resolution real-
time images of the microvasculature of abdominal organs in live
mice; 2) all of the abdominal organs examined (pancreas, psoas mus-
cles, liver, kidneys, and colon) have a unique set of vascular pheno-
types consisted of vessel diameter, density, and fractal dimension; 3)
normal pancreatic microvasculature can be categorized into three
groups based on their diameter, and PDAC vasculature differs from
this normal signature, with the larger-diameter vessels having greater
proportion; and 4) temporal progression of an orthotopic mouse
model of PDAC can be quantitatively characterized by changes in
vascular phenotypes.
Although our mechanistic understanding of oncogenesis has
grown tremendously, diagnosis of cancer remains mostly a qualitative
process done by interpreting radiologic images and tissue biopsies.
Histologic diagnosis remains the most frequently used method to
characterize tumor vessels, but it has several drawbacks. First, some
vascular conduits in the tumor are not endothelialized, whereas other
vessels might not be functional [13]. Hence, staining for endothelial
markers may not recapitulate the tumor microcirculation in vivo.
With histologic diagnosis, it is difficult to obtain representative per-
spectives of the tumor circulation because the cut surface dictates the
view. In addition, the removal of organs and tumors for histologic
diagnosis is often a terminal procedure for small animals, making
it impossible to track temporal changes in vasculature on the same
subject. The use of window chamber partially remedies these con-
cerns, but the data must be interpreted with caution because the
cancer cells are implanted subcutaneously, and not orthotopically.
As such, the tumor–host interaction more closely reflects that of me-
tastasis, rather than the growth of primary tumor in situ [14]. In
addition, the sustained immobilization of the tissue and the pressure
Figure 4. Histologic finding of normal pancreas and two orthotopic PDAC tumors with K-ras, Ink4a, and Arf mutations. (a) Hematoxylin
and eosin staining of normal pancreas showing an islet of Langerhans (yellow arrow) and the deeply basophilic columnar acinar cells
(red arrow). (b) A 2-week-old tumor derived from the NB587 cell line showing lymphocytic infiltrate (yellow arrow) and effacement of the
acinar architecture by the invading ductal cells (red arrow). (c) A 2-week-old tumor derived from the NB743 cell line harboring the same
mutations as NB587 and served here as an additional confirmation of phenotypes. Similar to (b), poorly formed glands were present in
densely fibrotic stroma (yellow arrow) within the pancreatic substance. Original magnifications, ×200. (d) IHC staining with anti-CD31
antibody for vessel diameter measurement validation. Blue bars were manually drawn by connecting the shortest point of an area en-
closed by positive staining (in light brown). Here, a normal pancreas is shown as an example. Black scale bar, 20 μm. (e) IHC staining of
PDAC shows tumor surface capillaries. (f) Intravital multichannel confocal microscopy on live PDAC revealed spatial relation between
tumor surface capillaries (false-colored in red) and the GFP+ tumors in green. Yellow scale bar, 200 μm.
Figure 5. Characterization of microvasculature of pancreatic ductal adenocarcinoma over time. (a) Tumor area from the same set of mice
(7 in each, 21 total) was measured at weeks 1 and 2. (b) Both lines of PDAC tumors did not show a significant change in vessel diameter
by week 1. However, by week 2, both had significantly larger-diameter vessels compared to the control. (c) Both lines of PDAC tumors
showed significant increase in vessel density by week 1; these differences became more accentuated by week 2. (d) Volume fraction
also became significantly greater for the tumors by week 1. (e) Fractal dimension did not change by week 1, but became significantly
elevated for both lines of tumor. (f) Lacunarity remained unchanged during the 2-week period. (g) A 3D scatterplot showing an increase
in vessel density, diameter, and fractal dimension secondary to orthotopic PDAC, represented by an upward shift in all axes from the
control group (dashed arrow). The two tumor lines mixed into one cluster. Each point represented one measurement.
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effect from the clamp may lead to unnatural perfusion and tissue
response [15].
Intravital microscopy has been made possible in recent years with
advances in scanning confocal and two-photon techniques, and these
improvements have enabled in vivo detection of orthotopic tumors
[16,17]. Whereas these approaches offer submicrometer lateral reso-
lution and the possibility of 3D reconstructions, they suffer from the
physical inflexibility inherent in the design of the microscope body
and lenses. For instance, the sample should ideally be flat on the sur-
face, a criterion hardly compatible with most organs in situ.
Fiber-optic–based confocal system circumvented this limitation
with a long, flexible microprobe that measures only a few millimeters
in diameter. The microprobe can pass through a 5-Fr sheath. Its
physical design allows for direct manual maneuver from the operator
and provides high-resolution image acquisition in real time. We were
able to use the system to image the abdominal viscera of nude mice
without mortality. No bleeding was observed. Macroscopic bleeding
could be seen during the procedure, whereas microscopic bleeding
would cause strong signal spreading on the screen as the fluorescent
blood pool agent leaked out of the vessels. Neither was observed in
any mice. Motion occurred at approximately once every 4 seconds as
the anesthetized mouse abruptly contracted its thoracic cage for deep
respiration. This motion could be minimized by lifting the pancreas
slightly toward the spleen and away from the rib.
Moreover, we were able to repeat the procedure on the same
mouse to track temporal changes in vascular phenotype of the pan-
creatic tumor. This was a remarkable breakthrough for intravital
imaging of the pancreas, which is always at risk of pancreatitis. Fur-
thermore, our measurement of vascular diameter was validated with
IHC staining with CD-31.
Another novelty of this study is the use of fractal analysis on
abdominal organs in situ. Fractal analysis has become increasingly
popular as a method to achieve more accurate geometrical analysis
of tumors, cells, and microvasculature morphology [18,19]. These
irregularly shaped entities defy description by traditional Euclidean
geometry that is based on smooth shapes such as the line, plane,
and cylinder [5,20]. A widely used parameter in fractal geometry is
the fractal dimension that measures the complexity and space-filling
property of an object [18]. A planar image of vasculature, for in-
stance, can take on a fractal dimension value between 1 and 2.
The more irregularly shaped and tortuous the vasculature, the closer
the fractal dimension approaches to 2.
Another fractal parameter is lacunarity that quantifies the heteroge-
neity of an image [11]. Qualitatively speaking, if every part of an image
resembles every other part, lacunarity would approach 0. A lacunarity
of 1 is the other extreme. In other words, higher lacunarity denotes
greater heterogeneity of the image. Fractal analysis has been widely
used to characterize tumor capillary in window chamber model
[5], but its use in less invasive and more physiologically relevant mod-
els has been limited to retinal and mucosal vasculature [21,22], where
noninvasive imaging could be readily performed on the exposed mi-
crovasculature using fundoscopy or macro lenses with an on-axis flash.
Using a fast blood vessel segmentation algorithm in conjunction
with fractal analysis, we characterized the microvasculature of five
different abdominal organs and provided a quantitative basis to com-
plement our knowledge of these organs. For instance, the kidney cor-
tex, rich in the leaky glomeruli, had the largest diameter vessel among
the five organs examined. The liver, with its complex sinusoid net-
work, carried the highest density and fractal dimension.
For our imaging system to be clinically translatable, it needs to de-
tect pathologic changes. Tumor capillary is known to be more tortuous
and leaky compared to normal vasculature, and angiogenesis is a re-
quirement for tumors to survive. Hence, the tumor microvasculature
provides an ideal setting for us to evaluate the fiber-optic imaging
Figure 6. Vessel diameter distribution and comparison between the normal pancreas and PDAC. This plot shows the pancreatic vas-
culature separated into three groups, and the PDAC profile showed a significantly different distribution pattern: higher groups 2 and
3 vessels compared to the normal pancreas.
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system. Pancreatic ductal adenocarcinoma remains one of the most ag-
gressive tumors; in fact, more than 80% of the tumor has metastasized
at initial diagnosis [23]. This grim statistic calls for better diagnostic
protocols to detect PDAC at earlier stages.
Activating K-ras mutations are found in greater than 90% of late-
stage PDAC and, along with the inactivation of tumor-suppressor
genes Ink4a and Arf, constitutes the signature mutational profile of
PDAC [24]. Our orthotopic mouse model for PDAC faithfully re-
capitulated these genetic features and showed that tumor surface cap-
illary had greater vessel diameter [12]. This observation could be
due to both the vessels having wider lumen and/or the vessels being
leakier such that the fluorescent blood pool agent was able to perfuse
beyond the vascular border. Our vessel diameter distribution histo-
gram revealed a different pattern between PDAC and the normal
pancreas. If the observed increase in vessel diameter in PDAC is sec-
ondary to elevated permeability, we would not expect to see changes
in vascular diameter distribution because an increase in permeability,
in theory, would affect all microvasculature. Instead, we found that in
PDAC, there was a decrease in small-size vessels with diameter less
than 10 μm, with a concomitant increase in the proportion of mid-
(10–16 μm) to large-sized (above 16 μm) vessels. Moreover, because
we imaged the vasculature immediately after intravenous injection of
the fluorescent blood pool agent, there was a very limited time win-
dow for significant degrees of imaging probe extravasation to occur.
In addition, the imaging probe used here has a large molecular
weight and has PEGylated chains that allow it to stay in the vascular
space with a half-life of more than 2 hours [25]. This line of thoughts
suggests that the detected increase in vessel diameter truly reflected
an enlargement of the vessel lumen. The increase in both vessel di-
ameter and density most likely contributed to the observed elevation
in vascular density and volume fraction.
Given that our imaging system has a penetration depth of only
15 μm, our observations that the PDAC vasculature is more com-
plex and dense are restricted only to the surface of the tumor. Our
imaging microprobe was not designed to cut through soft tissues, and
we did not reach to the core of the tumor to study the vascular
environment there, although prior data have indicated that the tumor
core is mostly avascular and is filled with necrotic debris [26].
The vessels imaged in this work were functional tumor surface
capillaries. Multichannel confocal microscopy showed that these ves-
sels were perfused, and hence functional, and that they traversed
through the tumors and appeared to be terminally branched as op-
posed to being a larger conduit vessels with additional branching into
smaller capillaries.
Our fractal analysis, for the first time, quantitatively showed that
PDAC vasculature was more complex than the normal counterpart.
Meanwhile, the heterogeneity of the vasculature remained unchanged,
suggesting that no parts of the tumor surface were preferentially receiv-
ing more blood supply than others. Of note, we obtained consistent
findings on vascular changes from two different PDAC primary cell
lines. This suggests that the observed changes in vascular phenotypes
were not isolated phenomena associated with a specific cell line, but
a reflection of PDAC in general. In other words, these changes were
likely due to the genetic alterations of the tumor cells per se, as opposed
to confounding epigenetic variables.
Finally, we were able to image and follow the growth of the same
tumor during a 2-week period. By week 1, only increases in vascular
density and vascular volume fraction were observed. No significant
changes in other vascular phenotypes were found, suggesting that
most vascular changes occur in the second week, during which the
tumor size also increased at least four-fold. This implies that the
growth of the microvasculature is the earliest change in PDAC,
and it preceded the significant growth of the tumor. This is consis-
tent with the notion that angiogenesis is required before tumors
could expand its size beyond a few cubic millimeters. The vascular
diameter distribution also did not show changes 1 week after implan-
tation of the tumor cells. Because a difference in the distribution of
vascular diameter was observed by week 2, this variation between the
normal pancreas and PDAC vasculature could potentially be applied
for diagnostic purpose.
We have shown that the fiber-optic confocal setup not only made
in vivo vascular imaging of abdominal organs possible, but it also
detected changes in orthotopic pancreatic tumor surface capillary
2 weeks after implantation. This clinically approved imaging system,
along with the postacquisition phenotype and fractal analyses, could
potentially be applied to monitor vascular changes in response to
therapy and complement current diagnostic imaging procedures to
achieve better disease detection.
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